Clinical trials
Completed Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
964 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 32 |
| 2001 | 27 |
| 2002 | 36 |
| 2003 | 36 |
| 2004 | 29 |
| 2005 | 54 |
| 2006 | 41 |
| 2007 | 60 |
| 2008 | 56 |
| 2009 | 49 |
| 2010 | 49 |
| 2011 | 39 |
| 2012 | 43 |
| 2013 | 57 |
| 2014 | 44 |
| 2015 | 38 |
| 2016 | 38 |
| 2017 | 31 |
| 2018 | 32 |
| 2019 | 18 |
| 2020 | 21 |
| 2021 | 20 |
| 2022 | 10 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 964 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 82 |
| Memorial Sloan Kettering Cancer Center | 42 |
| Celgene | 37 |
| Fred Hutchinson Cancer Center | 35 |
| National Heart, Lung, and Blood Institute (NHLBI) | 26 |
| National Cancer Institute (NCI) | 22 |
| Novartis Pharmaceuticals | 21 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 20 |
| Case Comprehensive Cancer Center | 18 |
| Masonic Cancer Center, University of Minnesota | 18 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 964 |
| Leukemia, Myeloid, Acute | 531 |
| Leukemia | 372 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 286 |
| Leukemia, Myelomonocytic, Chronic | 210 |
| Lymphoma, Non-Hodgkin | 207 |
| Myeloproliferative Disorders | 198 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 189 |
| Hodgkin Disease | 186 |
| Multiple Myeloma | 184 |
Trials
Showing 1 to 25 of 964. Each trial links to its page on Pharma Observatory.
864 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.